Trial NCT01287221

View at ClinicalTrials.gov 
Org. Study IDs: 10-003108
Secondary IDs: P01NS044233 U54NS065736

Last trial update was posted on 2014-03-28

MeSH Interventions

Riboflavin Rifampin

MeSH Conditions

Atrophy Multiple System Atrophy Shy-Drager Syndrome

Other Conditions


Stopping Reasons

DSMB recommended stopping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.

Limitations And Caveats

The study was terminated early; the Data Safety and Monitoring Board recommended stopping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID